Advanced Squamous Cell Lung Cancer Drug Giotrif Gets Thumbs-Up from EMA’s Committee for Medicinal Products
Lung Cancer, News
Boehringer Ingelheim announced a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for the company’s product Giotrif (afatinib) for the treatment of advanced squamous cell ... Read more